VeraDermics Inc. is a dermatology pharmaceutical start-up, makers of WartPatch
Location: United States
Employees: 1-10
Total raised: $225M
Founded date: 2019
Investors 2
| Date | Name | Website |
| - | Connecticu... | ctinnovati... |
| 10.07.2026 | Longitude ... | longitudec... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.10.2025 | Series C | $150M | Viking Glo... |
| 18.12.2024 | Series B | $75M | - |
Mentions in press and media 13
| Date | Title | Description |
| 18.08.2026 | Founder Of The Week: Andrea Clewett | Andrea Clewett is the co-founder of Showerscape, a Snowdania-based business that creates custom-printed shower panels for bathrooms, kitchens and swimming pools, serving both residential and commercial customers. The idea for Showerscape ca... |
| 15.07.2026 | Extended-Release Oral Minoxidil Posts First Efficacy Win in Women With Hair Loss | By Russell White Published: Jul 15 2026, 10:43 AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 22.04.2026 | Connecticut Innovations: $6 Million Invested Across Early-Stage Companies And Funds In Q3 | Connecticut Innovations announced it invested approximately $6 million across 15 companies and venture funds during the third quarter of its fiscal year, while helping attract $295.3 million in additional outside capital. The investments we... |
| 12.02.2026 | NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell | NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Feb. 12, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE P... |
| 04.02.2026 | NYSE Content Update: Disney Names New CEO After Ringing Bell on Main Street USA | NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Feb. 4, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pr... |
| 20.10.2025 | Veradermics: $150 Million Series C Raised For Advancing Late-Stage Trials Of VDPHL01 | Veradermics, a dermatologist-founded, late clinical-stage biopharmaceutical company developing first-in-class treatments for common dermatologic conditions, has announced the completion of an oversubscribed $150 million Series C financing r... |
| 18.12.2024 | Veradermics Grabs $75 Million in Series B Financing | NEW HAVEN, CT, Veradermics, a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions, announced the closing of a $75 million Series B finan... |
| 14.12.2024 | Veradermics Secures $75 Million to Tackle Hair Loss Epidemic | In a world where appearances often dictate confidence, hair loss can feel like a thief in the night. It creeps in silently, leaving millions grappling with its emotional toll. Enter Veradermics, a New Haven-based biopharmaceutical company, ... |
| 14.12.2024 | Veradermics: $75 Million (Series B) Raised To Develop Therapeutics For Common Dermatologic Conditions | Veradermics – a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions – announced the closing of a $75 million Series B financing. The fina... |
| 11.12.2024 | Veradermics Raises $75M in Series B Financing | Veradermics, a New Haven, CT-based clinical-stage aesthetics and dermatology-focused biopharmaceutical company, raised $75M in Series B funding. The round was led by Suvretta Capital Management and included new investors Longitude Capital, ... |
Show more